Table 1.

Patients who developed microalbuminuria according to baseline BP, follow-up BP, and BP reduction above or below the median and according to ACEi and ndCCB treatment^a

Parameter	SBP		DBP		MAP		Pulse Pressure
Parameter	Below	Above	Below	Above	Below	Above	Below	Above
Median baseline BP (mmHg)	150.00		88.33		108.33		61.67
median	44	57	48	53	52	49	51	50
ACEi no	28	38	29	37	31	35	35	31
ACEi yes	16^g	19^f	19	16^f	21^g	14^f	16^f	19^g
CCB no	24	24	24	24	27	21	27	21
CCB yes	20	33	24	29	25	28	24	29
Median follow-up BP (mmHg)	139.16		81.33		100.57		57.60
median	38	63^b	41	60^c	37	64^b	41	60^c
ACEi no	20	46^b	23	43^d	20	46^c	25	41^d
ACEi yes	18	17^f	18	17^f	17	18^f	16	19^f
CCB no	22	26	22	26	22	26	18	30^c
CCB yes	16	37^b	19	34^c	15	38^b	23	30
Median BP reduction (mmHg)	10.78		6.09		7.71		4.58
median	58	43^c	57	44^c	60	41^b	59	42^d
ACEi no	43	23^c	38	28	43	23^c	42	24^d
ACEi yes	15^e	20	19^g	16^d ^f	17^f	18	17^e	18^e
CCB no	27	21	24	24	28	20^d	29	19^d
CCB yes	31	22^d	33	20^c	32	21^c	30	23

↵^a ACEi, angiotensin-converting enzyme inhibitor; DBP, diastolic BP; MAP, mean arterial pressure; ndCCB, nondihydropyridine calcium channel blocker; SBP, systolic BP.
↵^b P ≤ 0.001,
↵^c P ≤ 0.01,
↵^d P < 0.05 versus below;
↵^e P ≤ 0.001,
↵^f P ≤ 0.01,
↵^g P < 0.05 versus ACEi no.